Aligos TherapeuticsALGS
13F holders, Q4 2025 (December 31)At the end of Q4 2025, 39 institutions reported holding Aligos Therapeutics Inc. (ALGS) in their 13F filings, up 6 from Q3 2025. 11 opened new positions and 5 sold out. The largest holders were Deep Track Capital, LP ($4.1M), Alyeska Investment Group, L.P. ($3.8M) and Sio Capital Management, LLC ($3.1M). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Aligos Therapeutics Inc.
- CUSIP
- 01626L204
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 11 | $5.3M |
| Exits | 5 | $3.8M |
All 13F filers, Q3 2025 → Q4 2025: 749,633 shares bought and 590,230 shares sold, net +159,403 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 39 holders
| Deep Track Capital, LP | 0.09% | No change | 444,110 | $4.1M |
| Alyeska Investment Group, L.P. | 0.01% | No change | 412,000 | $3.8M |
| Sio Capital Management, LLC | 0.52% | No change | 335,937 | $3.1M |
| Woodline Partners LP | 0.01% | Reduce -38.2% | 289,169 | $2.7M |
| Marshall Wace, LLP | 0.00% | New | 268,664 | $2.5M |
| Vanguard Group Inc. | 0.00% | Add +16.7% | 200,395 | $1.9M |
| SummitTX Capital, L.P. | 0.04% | New | 139,424 | $1.3M |
| Renaissance Technologies | 0.00% | Add +55.3% | 85,444 | $796K |
| Baker Bros. Advisors LP | 0.00% | No change | 83,055 | $774K |
| Two Sigma Investments, LP | 0.00% | Add +106.8% | 80,649 | $752K |
| HHLR Advisors, LTD. | 0.02% | No change | 76,247 | $711K |
| Verition Fund Management LLC | 0.00% | New | 71,254 | $664K |
| LPL Financial LLC | 0.00% | Add +19.7% | 66,000 | $615K |
| Citadel Advisors | 0.00% | Add +402.8% | 51,834 | $483K |
| Geode Capital Management, LLC | 0.00% | Add +1.4% | 47,741 | $445K |
| Jane Street Group, LLC | 0.00% | New | 24,293 | $226K |
| XTX Topco Ltd | 0.01% | New | 23,053 | $215K |
| AlphaQuest LLC | 0.01% | Add +104.9% | 13,876 | $129K |
| Bank of America Corp. | 0.00% | Add +584.9% | 13,108 | $122K |
| BlackRock, Inc. | 0.00% | No change | 13,040 | $122K |
| Two Sigma Advisers, LP | 0.00% | New | 13,000 | $121K |
| DRW Securities, LLC | 0.01% | New | 11,950 | $111K |
| HRT Financial LP | 0.00% | New | 11,374 | $106K |
| Rockefeller Capital Management L.P. | 0.00% | Add +900.0% | 10,000 | $93K |
| NorthCrest Asset Manangement, LLC | 0.00% | No change | 10,000 | $84K |
| FMR LLC | 0.00% | New | 4,972 | $46K |
| Golden State Wealth Management, LLC | 0.00% | No change | 2,674 | $25K |
| Morgan Stanley | 0.00% | Reduce -77.7% | 2,520 | $23K |
| Royal Bank of Canada | 0.00% | No change | 2,125 | $20K |
| Wells Fargo & Company | 0.00% | Reduce -52.7% | 1,500 | $14K |
| Summit Securities Group LLC | 0.00% | New | 500 | $5K |
| Global Retirement Partners, LLC | 0.00% | Reduce -50.0% | 400 | $4K |
| UBS Group AG | 0.00% | Reduce -97.8% | 364 | $3K |
| JPMorgan Chase & Co. | 0.00% | Reduce -56.8% | 306 | $3K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -91.5% | 39 | $363 |
| SBI Securities Co., Ltd. | 0.00% | No change | 26 | $242 |
| Elevation Wealth Partners, LLC | 0.00% | No change | 4 | $38 |
| BNP Paribas Financial Markets | 0.00% | No change | 3 | $28 |
| Citigroup Inc. | 0.00% | New | 1 | $9 |
"% of holder's portfolio" is ALGS's weight in each manager's 13F, not the share of Aligos Therapeutics Inc. the manager owns.